← The Wire
GANXNasdaq
Gain Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1819411
Develops novel small molecule therapeutics for CNS, LSDs, metabolic, and oncology diseases using its Magellan™ platform
$72M
Market cap
$1.98
Last close
+13.1%
1D
+7.0%
5D
12.5M
Volume
Price · last 39 sessions+4.2%
May 4L $1.59 · H $2.02Jun 29
106
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 29, 20268-KShareholder VoteJun 25, 20268-KCompany UpdateMay 26, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 202610-K10-KMar 26, 20268-KResults of OperationsMar 26, 20268-KReg FD Disclosure · Company UpdateMar 18, 20268-KReg FD DisclosureFeb 3, 20268-KCompany UpdateDec 18, 20258-KCompany UpdateNov 28, 2025424B5424B5Nov 28, 202510-Q10-QNov 12, 20258-KResults of OperationsNov 12, 20258-KReg FD DisclosureOct 14, 20258-KExecutive ChangeOct 9, 20258-KCompany UpdateOct 6, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 2025424B5424B5Jul 17, 20258-KMaterial Agreement · Equity IssuanceJul 17, 2025424B5424B5Jul 15, 20258-KCompany UpdateJun 30, 20258-KBylaw Amendment · Shareholder VoteJun 24, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KReg FD Disclosure · Company UpdateApr 10, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KReg FD DisclosureFeb 6, 20258-KDelisting NoticeJan 15, 20258-KExecutive Change · Reg FD DisclosureJan 7, 20258-KReg FD Disclosure · Company UpdateDec 23, 202410-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KCompany UpdateOct 21, 20248-KReg FD Disclosure · Company UpdateOct 8, 2024424B5424B5Sep 6, 20248-KMaterial AgreementSep 6, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KDelisting NoticeJul 12, 20248-KReg FD Disclosure · Company UpdateJul 9, 20248-KExecutive Change · Reg FD DisclosureJun 28, 20248-KShareholder VoteJun 25, 2024424B5424B5Jun 17, 20248-KMaterial Agreement · Reg FD DisclosureJun 14, 2024424B5424B5Jun 13, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive Change · Reg FD DisclosureApr 8, 202410-K10-KMar 26, 20248-KResults of OperationsMar 26, 20248-KExecutive ChangeFeb 22, 20248-KReg FD DisclosureJan 31, 2024S-1FORM S-1Dec 19, 2023424B5424B5Nov 24, 20238-KMaterial Agreement · Equity IssuanceNov 22, 2023424B5424B5Nov 20, 20238-KAgreement TerminatedNov 17, 202310-Q10-QNov 14, 20238-KResults of OperationsNov 14, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KShareholder VoteJun 26, 202310-Q10-QMay 12, 20238-KResults of OperationsMay 12, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeApr 28, 20238-KExecutive Change · Reg FD DisclosureApr 12, 202310-K10-KMar 23, 20238-KResults of OperationsMar 23, 20238-KExecutive ChangeDec 16, 2022
Similar companies
Comparable business profile · signals at a glance